258 related articles for article (PubMed ID: 7202134)
1. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids.
Moser HW; Moser AB; Frayer KK; Chen W; Schulman JD; O'Neill BP; Kishimoto Y
Neurology; 1981 Oct; 31(10):1241-9. PubMed ID: 7202134
[TBL] [Abstract][Full Text] [Related]
2. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts.
Moser HW; Moser AB; Kawamura N; Murphy J; Suzuki K; Schaumburg H; Kishimoto Y
Ann Neurol; 1980 Jun; 7(6):542-9. PubMed ID: 7436359
[TBL] [Abstract][Full Text] [Related]
3. Very long-chain fatty acids in erythrocyte membrane sphingomyelin: detection of ALD hemizygotes and heterozygotes.
Tanaka K; Shimada M; Naruto T; Yamamoto H; Saeki Y; Sai H; Hirose G
Neurology; 1986 Jun; 36(6):791-5. PubMed ID: 3703284
[TBL] [Abstract][Full Text] [Related]
4. Determination of C20-C30 fatty acids by reversed-phase chromatographic techniques: an efficient method to quantitate minor fatty acids in serum of patients with adrenoleukodystrophy.
Alberghina M; Fiumara A; Pavone L; Giuffrida AM
Neurochem Res; 1984 Dec; 9(12):1719-27. PubMed ID: 6531070
[TBL] [Abstract][Full Text] [Related]
5. Identification of female carriers of adrenoleukodystrophy.
Moser HW; Moser AE; Trojak JE; Supplee SW
J Pediatr; 1983 Jul; 103(1):54-9. PubMed ID: 6864396
[TBL] [Abstract][Full Text] [Related]
6. Detection of adrenoleukodystrophy by increased C26:0 fatty acid levels in leukocytes.
Molzer B; Bernheimer H; Heller R; Toifl K; Vetterlein M
Clin Chim Acta; 1982 Nov; 125(3):299-305. PubMed ID: 7172439
[TBL] [Abstract][Full Text] [Related]
7. Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes.
Singh I; Moser AE; Moser HW; Kishimoto Y
Pediatr Res; 1984 Mar; 18(3):286-90. PubMed ID: 6728562
[TBL] [Abstract][Full Text] [Related]
8. Childhood form of adrenoleukodystrophy in the sucking infant.
Kodama S; Nishio H; Yokoyama S; Matsuo T; Yamano T; Shimada M
Pediatr Neurosci; 1985-1986; 12(4-5):252-6. PubMed ID: 3843624
[TBL] [Abstract][Full Text] [Related]
9. Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy.
Moser HW; Moser AE; Singh I; O'Neill BP
Ann Neurol; 1984 Dec; 16(6):628-41. PubMed ID: 6524872
[TBL] [Abstract][Full Text] [Related]
10. Adrenoleukodystrophy: diagnosis and carrier detection by determination of long-chain fatty acids in cultured fibroblasts.
Tönshoff B; Lehnert W; Ropers HH
Clin Genet; 1982 Jul; 22(1):25-9. PubMed ID: 7172473
[TBL] [Abstract][Full Text] [Related]
11. Adrenoleukodystrophy: detection of increased very long chain fatty acids by high-performance liquid chromatography.
Kobayashi T; Katayama M; Suzuki S; Tomoda H; Goto I; Kuroiwa Y
J Neurol; 1983; 230(4):209-15. PubMed ID: 6198480
[TBL] [Abstract][Full Text] [Related]
12. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls.
Moser AB; Kreiter N; Bezman L; Lu S; Raymond GV; Naidu S; Moser HW
Ann Neurol; 1999 Jan; 45(1):100-10. PubMed ID: 9894883
[TBL] [Abstract][Full Text] [Related]
13. Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids.
Rizzo WB; Watkins PA; Phillips MW; Cranin D; Campbell B; Avigan J
Neurology; 1986 Mar; 36(3):357-61. PubMed ID: 3951702
[TBL] [Abstract][Full Text] [Related]
14. Adrenoleukodystrophy: very long-chain fatty acid metabolism in fibroblasts.
Rizzo WB; Avigan J; Chemke J; Schulman JD
Neurology; 1984 Feb; 34(2):163-9. PubMed ID: 6538003
[TBL] [Abstract][Full Text] [Related]
15. Adrenoleukodystrophy in Israel: a genetic, clinical and biochemical study.
Chemke J; Lieberman E; Carmi R; Abarbanel Y; Costeff H; Goldhammer Y; Moser HW
Isr J Med Sci; 1984 Dec; 20(12):1123-32. PubMed ID: 6097565
[TBL] [Abstract][Full Text] [Related]
16. Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy.
Knazek RA; Rizzo WB; Schulman JD; Dave JR
J Clin Invest; 1983 Jul; 72(1):245-8. PubMed ID: 6874949
[TBL] [Abstract][Full Text] [Related]
17. Adrenoleukodystrophy: biochemical procedures in diagnosis, prevention and treatment.
Watkins PA; Naidu S; Moser HW
J Inherit Metab Dis; 1987; 10 Suppl 1():46-53. PubMed ID: 3119941
[TBL] [Abstract][Full Text] [Related]
18. Adrenoleukodystrophy: dietary oleic acid lowers hexacosanoate levels.
Rizzo WB; Phillips MW; Dammann AL; Leshner RT; Jennings SS; Avigan J; Proud VK
Ann Neurol; 1987 Mar; 21(3):232-9. PubMed ID: 3037987
[TBL] [Abstract][Full Text] [Related]
19. The correlation between biochemical and histopathological findings in adrenoleukodystrophy.
Reinecke CJ; Knoll DP; Pretorius PJ; Steyn HS; Simpson RH
J Neurol Sci; 1985 Aug; 70(1):21-38. PubMed ID: 4045498
[TBL] [Abstract][Full Text] [Related]
20. Capillary gas-liquid chromatographic-mass spectrometric measurement of very long chain (C22 to C26) fatty acids in microliter samples of plasma.
Aubourg P; Bougnères PF; Rocchiccioli F
J Lipid Res; 1985 Feb; 26(2):263-7. PubMed ID: 3989386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
